Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II prophylactic pegylated G-CSF in relapsed/refractory multiple myeloma on pomalidomide + dexamethasone
KCT0002985Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in multiple myeloma (MM), sponsored by Kyowa Kirin. Started Aug 2018; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on KCT0002985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002985.